Julia for biologists

E Roesch, JG Greener, AL MacLean, H Nassar… - Nature …, 2023 - nature.com
Major computational challenges exist in relation to the collection, curation, processing and
analysis of large genomic and imaging datasets, as well as the simulation of larger and …

Optimal use of intravenous tranexamic acid for hemorrhage prevention in pregnant women

HK Ahmadzia, NLC Luban, S Li, D Guo, A Miszta… - American journal of …, 2021 - Elsevier
Background Every 2 minutes, there is a pregnancy-related death worldwide, with one-third
caused by severe postpartum hemorrhage. Although international trials demonstrated the …

Randomized phase III study of enzalutamide compared with enzalutamide plus abiraterone for metastatic castration-resistant prostate cancer (Alliance A031201 trial)

MJ Morris, G Heller, DW Hillman, O Bobek… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE Enzalutamide and abiraterone both target androgen receptor signaling but via
different mechanisms. The mechanism of action of one drug may counteract the resistance …

Pharmacokinetics of piperacillin and tazobactam in critically Ill patients treated with continuous kidney replacement therapy: A mini‐review and population …

DJ Selig, JP DeLuca, KK Chung… - Journal of Clinical …, 2022 - Wiley Online Library
What is known and objective Timely and appropriate dosing of antibiotics is essential for the
treatment of bacterial sepsis. Critically ill patients treated with continuous kidney …

Dynamic PET-facilitated modeling and high-dose rifampin regimens for Staphylococcus aureus orthopedic implant–associated infections

O Gordon, DE Lee, B Liu, B Langevin… - Science translational …, 2021 - science.org
Staphylococcus aureus is a major human pathogen causing serious implant–associated
infections. Combination treatment with rifampin (10 to 15 mg/kg per day), which has dose …

[HTML][HTML] Pharmacokinetics of high-titer anti–SARS-CoV-2 human convalescent plasma in high-risk children

O Gordon, MK Brosnan, S Yoon, D Jung, K Littlefield… - JCI insight, 2022 - ncbi.nlm.nih.gov
BACKGROUND While most children who contract COVID-19 experience mild disease, high-
risk children with underlying conditions may develop severe disease, requiring …

Meropenem pharmacokinetics in critically ill patients with or without burn treated with or without continuous veno‐venous haemofiltration

DJ Selig, KS Akers, KK Chung… - British Journal of …, 2022 - Wiley Online Library
Introduction Severe burn injury involves widespread skin and tissue damage leading to
systemic inflammation, hypermetabolism and multi‐organ failure. The hypermetabolic phase …

Interspecies brain pbpk modeling platform to predict passive transport through the blood–brain barrier and assess target site disposition

P Mehta, A Soliman, L Rodriguez-Vera, S Schmidt… - Pharmaceutics, 2024 - mdpi.com
The high failure rate of central nervous system (CNS) drugs is partly associated with an
insufficient understanding of target site exposure. Blood–brain barrier (BBB) permeability …

Filter inference: A scalable nonlinear mixed effects inference approach for snapshot time series data

D Augustin, B Lambert, K Wang, AC Walz… - PLOS Computational …, 2023 - journals.plos.org
Variability is an intrinsic property of biological systems and is often at the heart of their
complex behaviour. Examples range from cell-to-cell variability in cell signalling pathways to …

Learning pharmacometric covariate model structures with symbolic regression networks

Y Wahlquist, J Sundell, K Soltesz - Journal of Pharmacokinetics and …, 2024 - Springer
Efficiently finding covariate model structures that minimize the need for random effects to
describe pharmacological data is challenging. The standard approach focuses on …